Quick Answer
Cannabis Bioscience International Holdings, Inc. reported Stockholders Equity of -$1.16 million for fiscal year 2025.
Cannabis Bioscience International Holdings, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$1.16M | -7.8% |
| 2024 | -$1.08M | -82.4% |
| 2023 | -$591.7K | -63.9% |
| 2022 | -$361.1K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | -$1.36M | -20.1% | -9.4% |
| August 31, 2025 | -$1.25M | -18.1% | -7.1% |
| May 31, 2025 | -$1.16M | -7.8% | -2.5% |
| November 30, 2024 | -$1.13M | -34.8% | -7.5% |
| August 31, 2024 | -$1.06M | -47.1% | +2.2% |
| May 31, 2024 | -$1.08M | -82.4% | -10.5% |
| February 29, 2024 | -$976.1K | -102.6% | -15.9% |
| November 30, 2023 | -$841.9K | -107.7% | -17.3% |
- Cannabis Bioscience International Holdings, Inc. showed a decrease of -7.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2025 period, Cannabis Bioscience International Holdings, Inc.’s stockholders equity has declined by 222.3% (from -$361.1 thousand to -$1.16 million).
- The most recent figure is from Cannabis Bioscience International Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: